Cboe Files to List Canary Capital’s Staked Injective ETF

Cboe BZX Exchange has officially filed to list the Staked Injective ETF, a novel product launched by Canary Capital that focuses on the Injective (INJ) cryptocurrency. This development reinforces the increasing integration between traditional financial markets and decentralized finance (DeFi) assets.

The ETF will provide investors streamlined exposure to the Injective token, which has gained momentum in crypto circles due to its role in decentralized derivatives and cross-chain trading platforms. Canary Capital's innovative structure involves staking the Injective tokens, aiming to deliver additional yield on top of price appreciation.

Cboe Expands Crypto ETF Offerings with Canary Capital

The regulatory filing, submitted on July 28, 2025, outlines the plan to list shares of the Staked Injective ETF under the ticker symbol "STINJ" on Cboe BZX Exchange. Canary Capital highlights the ETF’s objective to track the performance of Injective tokens that are actively staked within the network, capturing rewards generated from staking activities.

The launch aligns with the broader trend of exchanges seeking exposure to emerging blockchain projects via exchange-traded funds. Cboe's filing marks one of the first crypto ETFs focusing explicitly on staked assets rather than purely holding tokens. This approach intends to unlock a dual strategy for investors—benefiting from both price movements and yield from the staking mechanism.

According to Canary Capital, “The Staked Injective ETF presents a unique opportunity for market participants to access layer-one protocol exposure with yield, a feature largely absent in current ETF offerings.” This ability to earn staking rewards adds a compelling layer to traditional investment methods.

Injective Protocol’s Growing Appeal Drives ETF Demand

Injective Protocol, the underlying blockchain project, specializes in providing decentralized finance infrastructure, including derivatives trading and cross-chain interoperability. The protocol’s ecosystem has expanded rapidly, drawing interest from institutional and retail investors alike.

Canary Capital’s ETF filing notes that staked Injective tokens contribute to network security and liquidity, which justifies the potential for additional returns. The ETF will hold staked INJ tokens and periodically distribute staking rewards to shareholders, offering a new product that parallels direct participation in the staking process but with added liquidity and regulatory oversight.

Stakeholders have expressed enthusiasm about the ETF’s potential to bring DeFi-style income streams to traditional market investors. This product could help bridge crypto-native yield-generating assets with institutional capital flowing into regulated environments like the Cboe BZX Exchange.